MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B

Jun Gao(Inner Mongolia Medical University), R. Wang(Inner Mongolia Medical University)

Neoplasma

January 1, 2019

10.4149/neo_2018_180830n659

Cited by 20

Related Papers

Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy

|Oncogene|2023|44

Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma

|Nature Communications|2025|31

Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma

|癌症：英文版|2023|17